![]() |
市場調查報告書
商品編碼
1494780
到 2030 年手指和關節移植市場預測:按產品、材料、固定、設計、年齡層、應用、最終用戶和地區進行的全球分析Digit Joint Implants Market Forecasts to 2030 - Global Analysis By Product, Material, Fixation, Design, Age Group, Application, End User and By Geography |
根據 Stratistics MRC 的數據,2024 年全球關節移植市場規模為 7,238 萬美元,預計到 2030 年將達到 1.2409 億美元,預測期內複合年成長率為 9.4%。
指趾關節移植是一種義肢裝置,用於替換或加強受損或故障的指關節。這些植入通常由金屬或陶瓷等耐用材料製成,模仿自然關節的結構和功能,從而改善受影響手指的活動性和功能。透過恢復手指的活動範圍和穩定性,指趾關節移植可以改善手部功能受損人士的生活品質並促進日常生活活動。
根據 NCBI 2022 年 5 月更新的資料,骨關節炎影響全球約 3.3-3.6% 的人口,估計導致 4,300 萬人出現中度至重度殘疾。
外傷增加
事故、運動相關事件或職業危害等造成的創傷通常會導致指關節嚴重受損,需要手術介入才能恢復功能。指趾關節移植透過替換或修復受損關節提供了可行的解決方案,使患者能夠重新獲得活動能力和靈活性。由於外傷的持續發生,手指和關節移植的需求預計將增加並推動市場成長。
併發症的風險
指趾關節移植併發症的風險由多種因素引起,包括感染、植入失敗和神經損傷。這些併發症可能導致恢復時間更長、需要額外的手術並降低患者滿意度。這樣的結果不僅增加了醫療成本,也削弱了病患對手術和植入裝置的信任。因此,患者可能會選擇替代治療或完全推遲尋求醫療干預,從而阻礙市場成長。
材料科學的持續創新
材料科學領域的持續技術創新在推動關節移植市場的成長中發揮著至關重要的作用。生物相容性金屬、陶瓷和生物分解性聚合物等材料的進步正在開發更耐用、生物相容性和更具功能性的植入。這些創新使外科醫生能夠為指關節疾病患者提供更有效的治療方法,從而改善手術結果和患者滿意度。此外,材料科學領域的持續研發工作確保了下一代植入的誕生,並透過改進產品供應和治療功效推動市場進一步擴張。
替代治療方案
關節關節移植的替代治療方法包括非手術方法,例如物理治療、疼痛管理和生活方式改變。儘管這些替代療法可以暫時緩解症狀,但它們通常無法有效解決潛在的關節損傷。因此,患者可能會推遲手術或完全避免手術,從而影響對手指和關節移植的需求。此外,喜歡非侵入性方法的患者可能不願意考慮手術干預,這限制了市場潛力。
COVID-19 的影響
COVID-19 的爆發對手指和關節移植市場產生了各種影響。由於手術延遲和人們對醫療保健需求的認知提高,對包括關節關節重建在內的整形外科手術的需求激增,同時也造成了供應鏈中斷和獲得醫療保健設施的挑戰。此外,經濟不確定性和醫療保健優先事項的變化也影響著患者的決策和醫療保健支出。整體而言,市場經歷了供需動態波動,疫情對市場的影響既有正面影響,也有負面影響。
生物分解性植入產業預計將在預測期內成為最大的產業
生物分解性植入領域預計將出現良好的成長。生物分解性的植入是一種很有前途的人工關節移植,隨著時間的推移,它會在體內逐漸分解,從而無需進行切除手術。這些植入由聚合物和陶瓷等材料製成,可提供臨時支撐,同時促進組織再生。潛在的好處包括降低感染風險和改善癒合。
骨關節炎領域預計在預測期內複合年成長率最高
骨關節炎領域預計在預測期內複合年成長率最高。對於骨關節炎,手指和關節移植可恢復功能並緩解疼痛,尤其是手指關節。隨著骨關節炎的進展,軟骨劣化,導致關節僵硬不適。指趾關節移植提供了一種可行的治療選擇,可以增加關節活動度並改善整體手部功能和患者的生活品質。
預計亞太地區在預測期內將佔據最大的市場佔有率。人口老化、關節炎和手部損傷等疾病盛行率上升以及醫療基礎設施的改善是主要促進因素。此外,技術和手術技術的進步正在擴大治療選擇並改善患者的治療效果。中國、日本和印度等國家由於患者人數眾多且醫療保健支出不斷增加,正在成為利潤豐厚的市場。
由於人口老化中創傷性損傷和退化性關節疾病的盛行率不斷增加,預計北美在預測期內將呈現最高的複合年成長率。植入技術的進步和對微創手術的日益偏好進一步刺激了市場成長。此外,醫療保健支出的增加和患者意識的提高也有助於該地區市場的持續擴張。
According to Stratistics MRC, the Global Digit Joint Implants Market is accounted for $72.38 million in 2024 and is expected to reach $124.09 million by 2030 growing at a CAGR of 9.4% during the forecast period. Digit joint implants are prosthetic devices used to replace or augment damaged or dysfunctional finger joints. Typically composed of durable materials like metal or ceramic, these implants mimic the structure and function of natural joints, enabling improved mobility and functionality in the affected digits. By restoring range of motion and stability to the fingers, digit joint implants can enhance quality of life and facilitate activities of daily living for individuals with compromised hand function.
According to the data updated by NCBI in May 2022, it is estimated that osteoarthritis affects about 3.3 to 3.6% of the population globally and it causes moderate to severe disability in 43 million people, making it the 11th most debilitating disease worldwide.
Rising prevalence of traumatic injuries
Traumatic injuries, such as those resulting from accidents, sports-related incidents, or occupational hazards, often lead to severe damage to finger joints, necessitating surgical intervention for restoration of function. Digit joint implants offer a viable solution by replacing or repairing damaged joints, enabling patients to regain mobility and dexterity. As traumatic injuries continue to occur, the demand for digit joint implants is expected to increase, driving market growth.
Risk of complications
The risk of complications in digit joint implants arises from various factors such as infection, implant failure, and nerve damage. These complications can lead to prolonged recovery periods, additional surgeries, and decreased patient satisfaction. Such outcomes not only increase healthcare costs but also erode patient confidence in the procedure and the implanted devices. Consequently, it hampers market growth as patients may opt for alternative treatments or delay seeking medical intervention altogether.
Continuous innovations in material science
Continuous innovations in material science play a pivotal role in propelling the growth of the digit joint implants market. Advancements in materials such as biocompatible metals, ceramics, and biodegradable polymers have led to the development of implants with enhanced durability, biocompatibility, and functionality. These innovations enable surgeons to provide more effective treatment options for patients with digit joint disorders, leading to improved surgical outcomes and patient satisfaction. Moreover, ongoing R&D efforts in material science ensure the creation of next-generation implants, driving further market expansion through improved product offerings and treatment efficacy.
Alternative treatment options
Alternative treatment options to digit joint implants include non-surgical approaches like physical therapy, pain management, and lifestyle modifications. While these alternatives may offer temporary relief, they often fail to address the underlying joint damage effectively. Consequently, patients may postpone or avoid surgery altogether, impacting the demand for digit joint implants. Additionally, the preference for non-invasive methods can deter patients from considering surgical interventions, limiting the market potential.
Covid-19 Impact
The covid-19 pandemic has had a mixed impact on the digit joint implants market. While there has been a surge in demand for orthopedic procedures, including joint replacements, due to postponed surgeries and increased awareness of healthcare needs, there have also been disruptions in the supply chain and challenges in accessing healthcare facilities. Additionally, economic uncertainties and shifting healthcare priorities have influenced patient decisions and healthcare expenditure. Overall, the market has experienced fluctuations in demand and supply dynamics, with both positive and negative impacts attributable to the pandemic.
The biodegradable implants segment is expected to be the largest during the forecast period
The biodegradable implants segment is estimated to have a lucrative growth. Biodegradable implants are a promising type of digit joint implant that gradually degrades within the body over time, eliminating the need for removal surgeries. Made from materials like polymers or ceramics, these implants provide temporary support while promoting tissue regeneration. They offer potential advantages such as reduced risk of infection and improved healing.
The osteoarthritis segment is expected to have the highest CAGR during the forecast period
The osteoarthritis segment is anticipated to witness the highest CAGR growth during the forecast period. In the context of osteoarthritis, digit joint implants offer relief by restoring function and alleviating pain in affected joints, particularly in the fingers. As osteoarthritis progresses, cartilage deteriorate, leading to joint stiffness and discomfort. Digit joint implants provide a viable treatment option, enhancing joint mobility and improving overall hand function and patients' quality of life.
Asia Pacific is projected to hold the largest market share during the forecast period. Rising geriatric population, increasing prevalence of conditions like arthritis and hand injuries, and improving healthcare infrastructure are key drivers. Moreover, advancements in technology and surgical techniques are expanding treatment options and enhancing patient outcomes. Countries such as China, Japan, and India are emerging as lucrative markets due to large patient populations and increasing healthcare spending.
North America is projected to have the highest CAGR over the forecast period, owing to the increasing prevalence of traumatic injuries and degenerative joint diseases among the aging population. Advancements in implant technology and a growing preference for minimally invasive procedures further stimulate market growth. Further, rising healthcare expenditure and improving patient awareness contribute to sustained market expansion in the region.
Key players in the market
Some of the key players profiled in the Digit Joint Implants Market include Johnson & Johnson Medical Devices Company, Wright Medical Group, Teijin Nakashima Medical Corporation, Smith & Nephew, Stryker Corporation, Integra Lifesciences, Acumed LLC, Merete Medical GmbH, Zimmer Biomet Holdings Inc., Vilex in Tennessee Inc., Signature Orthopedics Implants, Anika Therapeutics, Beznoska, Skeletal Dynamics, in2bones and Evolutis.
In September 2023, Stryker launched minimally invasive surgical bunion treatment. The new technology features MIS joint preparation, triplanar reduction and a three-screw construct that creates a tension band for biomechanical stability.
In May 2022, CONMED Corporation signed a definitive agreement to acquire privately-held In2Bones Global, Inc. In2Bones is a global developer, manufacturer, and distributor of medical devices for the treatment of disorders and injuries of the upper (hand, wrist, elbow) and lower (foot and ankle) extremities. The company's comprehensive product portfolio includes implants, fracture systems, biologics, and related hardware.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.